Price $16.04 |
Market Cap
699.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
-
|
Dividend %
-
|
|
P/CF
58.9
|
P/FCF
-
|
Op. Cash Flow
-143.7K
|
FCF
-3.4
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-49.60%
|
|
ROA
-74.70%
|
EPS Growth
-41.60%
|
Current Ratio
10.2
|
Debt/Equity
347.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
